Mesothelioma early detection can be a real boon when it comes to fighting the disease.  While that seems to stands to reason—many diseases, it would seem, would be more likely to be treatable when detected early—this is also true when it comes to this devastating cancer caused by asbestos, according to an article on Asbestos.com.

According to the article, receiving an early diagnosis of mesothelioma might be harder than it seems.  There are a few reasons for this.  First, the cancer is so rare, with a prevalence of just 40 per 1,000,000 population in this country, that many doctors overlook it as a diagnosis option.  What’s more, its symptoms oftentimes resemble those of other, more common diseases, so mesothelioma often might not even cross a physician’s mind.

The article goes on to point out a couple of useful early detection methods.  One of them is called Mesomark, and it’s a blood test that measures the amount of Soluble Mesothelin-Related Peptides in the sample.  These SMRPs might be present in mesothelioma patients, which, in turn, might indicate the development of mesothelioma to physicians performing the test.

Though early detection, as previously mentioned, might be able to increase the quality of life and/or life expectancy of mesothelioma patients, this is still a crushing disease.  Though there are treatments, which may lessen suffering or slow its advance, there is, unfortunately, no cure.  What’s worse, the life expectancy of a victim suffering with mesothelioma can often be measured in just months.

Mesothelioma is most often caused by exposure to asbestos, a fibrous mineral that had been used for many years in several industries, especially the fields of shipbuilding and construction.  Asbestos was utilized for its lightweight flame-retardant and insulation properties; however, when inhaled, it’s incredibly dangerous, and can often lead to potentially lethal diseases such as mesothelioma and asbestosis.